Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
UROPLASTY INC (UPI)
|
Add to portfolio |
|
|
|
| Price: |
$0.30
| | Metrics |
| OS: |
22.1
|
M
| |
-74
|
% ROE
|
| Market cap: |
$6.64
|
M
| |
-567
|
% ROIC
|
|
Net cash:
|
$8.68
|
M
| |
$0.39
|
per share
|
|
EV:
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($6.2)
|
M
| |
|
|
|
EBIT
|
($6.5)
|
M
| |
|
|
| EPS |
($0.30)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Mar-31-14 | Mar-31-13 | Mar-31-12 | Mar-31-11 | Mar-31-10 | Mar-31-09 | Mar-31-08 | Mar-31-07 |
| Revenues | 24.6 | 22.4 | 20.6 | 13.8 | 11.9 | 14.7 | 13.9 | 8.3 |
| Revenue growth | 9.6% | 9.0% | 49.1% | 16.2% | -19.5% | 6.4% | 66.7% | |
| Cost of goods sold | 3.0 | 3.0 | 3.0 | 2.4 | 2.1 | 2.3 | 2.9 | 2.6 |
| Gross profit | 21.5 | 19.4 | 17.5 | 11.4 | 9.8 | 12.5 | 10.9 | 5.7 |
| Gross margin | 87.6% | 86.6% | 85.2% | 82.7% | 82.6% | 84.5% | 78.8% | 68.8% |
| Sales and marketing | 18.1 | 15.2 | 15.3 | 10.1 | 7.6 | 9.3 | 8.5 | 5.2 |
| Research and development | 2.2 | 2.4 | 1.9 | 1.7 | 1.8 | 2.6 | 1.8 | 2.3 |
| General and administrative | 6.5 | 4.2 | 3.7 | 3.4 | 2.8 | 3.4 | 3.7 | 3.1 |
| EBITA | -5.3 | -2.4 | -3.4 | -3.9 | -2.4 | -2.8 | -3.1 | -4.9 |
| EBITA margin | -21.4% | -10.9% | -16.6% | -28.0% | -19.9% | -18.8% | -22.3% | -58.6% |
| Amortization of intangibles | 0.0 | 0.9 | 0.9 | 0.8 | 0.8 | 0.8 | 0.8 | 0.1 |
| EBIT | -5.3 | -3.3 | -4.3 | -4.7 | -3.2 | -3.6 | -3.9 | -5.0 |
| EBIT margin | -21.6% | -14.7% | -20.7% | -34.1% | -27.0% | -24.6% | -28.4% | -59.8% |
| Pre-tax income | -5.3 | -3.3 | -4.2 | -4.6 | -3.2 | -3.5 | -3.8 | -4.8 |
| Income taxes | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 |
| Net income | -5.4 | -3.3 | -4.3 | -4.6 | -3.2 | -3.6 | -3.8 | -5.0 |
| Net margin | -21.8% | -14.7% | -20.7% | -33.7% | -27.0% | -24.3% | -27.6% | -59.9% |
| |
| Diluted EPS | ($0.25) | ($0.16) | ($0.21) | ($0.25) | ($0.21) | ($0.24) | ($0.28) | ($0.58) |
| Shares outstanding (diluted) | 21.1 | 20.8 | 20.7 | 18.9 | 14.9 | 14.9 | 13.8 | 8.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|